Article

HHS Decides Not to Leapfrog to ICD-11

Word of the new ICD-10 compliance deadline came as welcome news to many in the healthcare realm — just not everyone.

There remains a corner of the industry that publicly asked the Department of Health and Human Services (HHS) to consider other alternatives, most notably ICD-11, before mandating a new deadline.

Read the full story: http://bit.ly/NAp9st

Source: Healthcare Finance News

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
Mehmet Oz, MD, MBA
Hira Ghani, DO, discusses underdiagnosed skin conditions in children
Nicole Bajic, MD
World Hepatitis Day graphic | Image Credit: uazzal - stock.adobe.com
2 experts in this video
Related Content
PA form | Image: Adobe Stock
July 25th 2025

KFF Survey: Most Consumers Find Prior Authorization Is a Major Problem

Mary Caffrey
A new survey reveals widespread consumer frustration with prior authorization, highlighting the need for urgent reform in insurance coverage.
managed care cast logo
July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.
Lungsandheart | Image Credit: Kiattisak-stock.adobe.com
July 25th 2025

Genetic Study Finds Hypothyroidism May Increase PAH Risk

Maggie L. Shaw
A nascent hypothesis regarding pulmonary arterial hypertension (PAH) is that there is a link between thyroid dysfunction and PAH risk; much remains to be investigated to prove causality.
Managed Care Cast
Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey
Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization
Topical cream for AD | Image credit: Ladanifer - stock.adobe.com
July 25th 2025

Across 8 Trials, Ruxolitinib Cream Shows Favorable Safety in Pediatric AD

Pearl Steinzor
A poster at the Society for Pediatric Dermatology Annual Meeting presented an integrated safety analysis showing rare or no serious adverse events linked to topical Janus kinase inhibitor use in children with atopic dermatitis (AD).
Contributor: When AI Sees, Yet Cannot Judge—Why Health Care Must Remain Human-Led
July 25th 2025

Contributor: When AI Sees, Yet Cannot Judge—Why Health Care Must Remain Human-Led

Andy Truscott
Although artificial intelligence (AI) is quickly becoming a tool used in health care, the human aspect of health care is still necessary for continued care.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo